共 363 条
[1]
Zhou F(2019)Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis Hepatol 70 1119-1133
[2]
Zhou J(2018)Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 J Hepatol 69 896-904
[3]
Wang W(2015)Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese Medicine (Baltimore) 94 e1682-e3968
[4]
Zhang XJ(2021)New nonalcoholic fatty liver disease and fibrosis progression associate with the risk of incident chronic kidney disease J Clin Endocrinol Metab 106 e3957-251
[5]
Ji YX(2017)Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial Drug Res (Stuttg) 67 244-31
[6]
Zhang P(2014)Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis PLoS Med 11 e1001680-1630
[7]
She ZG(2013)Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis Obes Rev 14 417-280
[8]
Zhu L(2020)Dysregulated lipid metabolism links NAFLD to cardiovascular disease Mol Metab 42 101092-1374
[9]
Cai J(2019)Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor alpha in high-fat-diet-fed C57BL/6J mice Int J Obes (Lond) 43 1620-451
[10]
Li H(2012)Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice Hepatol 56 270-469